The ABCs of cancer stem cell drug resistance

IDrugs

Volumn 13, Issue 9, 2010, Pages 632-635

  Elliot, A ^a   Adams, J ^a   Al Hajj, M ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; ADENOSINE TRIPHOSPHATASE; BCR ABL PROTEIN; BREAST CANCER RESISTANCE PROTEIN; DOXORUBICIN; GEFITINIB; LAPATINIB; METHOTREXATE; MITOXANTRONE; MULTIDRUG RESISTANCE PROTEIN 1; PACLITAXEL; TOPOTECAN; ANTINEOPLASTIC AGENT;

CANCER RELAPSE; CANCER STEM CELL; CELL PROLIFERATION; CELL PROTECTION; CELL VIABILITY; DRUG BINDING; DRUG EFFICACY; DRUG MECHANISM; DRUG SENSITIVITY; DRUG TARGETING; DRUG TRANSPORT; ENZYME ACTIVITY; ENZYME INHIBITION; MULTIDRUG RESISTANCE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; STEM CELL; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; DRUG RESISTANCE; GENETICS; HUMAN; METABOLISM; NEOPLASMS; TRANSPORT AT THE CELLULAR LEVEL;

ANTINEOPLASTIC AGENTS; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; HUMANS; NEOPLASMS; NEOPLASTIC STEM CELLS;

EID: 77956169003     PISSN: 13697056     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (10)

1. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clark MF: Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA (2003) 100(7):3983-3988.
2. Chaudhary PM, Roninson IB: Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells. Cell (1991) 66(1):85-94.
3. Coley HM: Overcoming multidrug resistance in cancer: Clinical studies of P-glycoprotein inhibitors. Methods Mol Biol (2010) 596:341-358.
4. Dean M, Fojo T, Bates S: Tumor stem cells and drug resistance. Nat Rev Cancer (2005) 5(4):275-284.
5. Elliott AM, Al-Hajj MA: ABCB8 mediates doxorubicin resistance in melanoma cells by protecting the mitochondrial genome. Mol Cancer Res (2009) 7(1):79-87.
6. Eng KT, Berdis AJ: A novel non-natural nucleoside that influences P-glycoprotein activity and mediates drug resistance. Biochemistry (2010) 49(8):1640-1648.
7. Gottesman MM, Fojo T, Bates SE: Multidrug resistance in cancer: Role of ATP-dependent transporters. Nat Rev Cancer (2002) 2(1):48-58.
8. Hegedus C, Ozvegy-Laczka C, Szakács G, Sarkadi B: Interaction of ABC multidrug transporters with anticancer protein kinase inhibitors: Substrates and/or inhibitors? Curr Cancer Drug Targets (2009) 9(3):252-272.
9. van de Ven R, Oerlemans R, van der Heijden JW, Scheffer GL, de Gruijl TD, Jansen G, Scheper RJ: ABC drug transporters and immunity: Novel therapeutic targets in autoimmunity and cancer. J Leukoc Biol (2009) 86(5):1075-1087.
10. Zhou S, Schuetz JD, Bunting KD, Colapietro AM, Sampath J, Morris JJ, Lagutina I, Grosveld GC, Osawa M, Nakauchi H, Sorrentino BP: The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat Med (2001) 7(9):1028-1034